Shamrock Asset Management’s Novo Nordisk NVO Stock Holding History

Shamrock Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$506K	Sell	19,568 -784	-4%	-$19.8K	0.39%	63
2019 Q2	$519K	Buy	20,352 +1,058	+5%	+$26.1K	0.37%	65
2019 Q1	$505K	Sell	19,294 -72	-0.4%	-$1.77K	0.4%	58
2018 Q4	$446K	Hold	19,366	–	–	0.67%	46
2018 Q3	$456K	Hold	19,366	–	–	0.29%	70
2018 Q2	$447K	Hold	19,366	–	–	0.27%	78
2018 Q1	$471K	Sell	19,366 -690	-3%	-$18.1K	0.28%	75
2017 Q4	$538K	Hold	20,056	–	–	0.32%	62
2017 Q3	$483K	Sell	20,056 -282	-1%	-$6.37K	0.31%	60
2017 Q2	$436K	Sell	20,338 -418	-2%	-$8.44K	0.27%	65
2017 Q1	$356K	Buy	20,756 +668	+3%	+$11.6K	0.22%	78
2016 Q4	$360K	Sell	20,088 -2,534	-11%	-$45.9K	0.22%	76
2016 Q3	$473K	Sell	22,622 -424	-2%	-$10.5K	0.27%	69
2016 Q2	$620K	Sell	23,046 -462	-2%	-$12.7K	0.36%	53
2016 Q1	$637K	Sell	23,508 -29,798	-56%	-$798K	0.38%	47
2015 Q4	$1.55M	Sell	53,306 -2,826	-5%	-$78.2K	0.87%	13
2015 Q3	$1.52M	Sell	56,132 -3,924	-7%	-$111K	0.81%	10
2015 Q2	$1.64M	Sell	60,056 -11,110	-16%	-$312K	0.76%	17
2015 Q1	$1.9M	Buy	+71,166	New	+$1.64M	0.76%	18

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Shamrock Asset Management's NVO Position: Q3 2019 in Review

Shamrock Asset Management reduced its Novo Nordisk (NVO) stake by 3.9% in Q3 2019, selling an estimated $19.8K and leaving 19,568 shares worth $506K. The position accounts for 0.39% of the portfolio, ranked #63.

Shamrock Asset Management first reported a position in NVO in Q1 2015 and has held it in 19 quarters since. The position peaked at $1.9M in Q1 2015. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

Shamrock Asset Management held 19,568 shares of Novo Nordisk worth $506K as of Q3 2019.
Shamrock Asset Management sold 784 Novo Nordisk shares in Q3 2019, an estimated $19.8K.
Novo Nordisk made up 0.39% of Shamrock Asset Management's portfolio in Q3 2019, its #63 holding.
Shamrock Asset Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 19 quarters since.
Shamrock Asset Management's Novo Nordisk position peaked at $1.9M in Q1 2015.
564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.